Approaches have been investigated which could increase endogenous mammary NIS expression by stimulation of putative regulators, but while some data is promising [12], [13], increased knowledge of breast cancer and mammary NIS regulatory mechanisms is required. The gene discussed is SLC5A5; the disease is breast carcinoma.